Long-term tamoxifen use may up aggressive breast cancer risk
August 26th, 2009 - 12:33 pm ICT by ANIWashington, Aug 26 (ANI): Tamoxifen drug, commonly used for treating breast cancer, can actually increase the severity of the disease, finds a new study.
The researchers showed that long-term tamoxifen use increases risk of an aggressive, hard to treat type of second breast cancer.
Lead researcher Dr Christopher Li at Fred Hutchinson Cancer Research Centre compared the breast-cancer patients who received the estrogen-blocking drug tamoxifen to those who did not and found that while the drug was associated with a 60 percent reduction in estrogen receptor-positive, or ER positive, second breast cancer - the more common type, which is responsive to estrogen-blocking therapy - it also appeared to increase the risk of ER negative second cancer by 440 percent.
“This is of concern, given the poorer prognosis of ER-negative tumors, which are also more difficult to treat,” said Li.
The findings from the new study supports Li’s earlier research suggesting a link between long-term tamoxifen use and an increased risk of ER-negative second cancers.
“The earlier study had a number of limitations. For example, we did not have information on the duration of tamoxifen therapy the women received,” said Li.
“The current study is larger, is based on much more detailed data, and is the first study specifically designed to determine whether tamoxifen use among breast cancer survivors influences their risk of different types of second breast cancers,” the expert added.
However, Li insists that while the study confirmed a strong association between long-term tamoxifen therapy and an increased risk of ER-negative second cancer, it does not suggest that breast cancer survivors should stop taking hormone therapy to prevent a second cancer.
The findings are published in the journal Cancer Research. (ANI)
- Oestrogen therapy 'causes ovarian cancer to grow five times faster' - Oct 21, 2010
- Chemo plus tamoxifen beneficial for some breast cancer patients - Dec 11, 2009
- Body fat distribution linked to a higher risk of ER-negative breast cancer - Dec 16, 2010
- Evidence of unusual drug-resistant breast tumours found - Oct 09, 2010
- 10 tips to steer clear of breast cancer - Oct 03, 2010
- Multiple childbirth linked to increased risk of 'triple-negative' breast cancer - Feb 25, 2011
- Obesity could increase aggressive breast cancer risk - Mar 02, 2011
- Soy food safe for breast cancer survivors - Apr 06, 2011
- Taking tamoxifen to prevent breast cancer can save lives and cut medical costs - Mar 14, 2011
- Gene mutation ups blood-clot risk in women taking breast cancer treatment - Jun 17, 2010
- Anti-estrogen medication 'cuts risk of dying from lung cancer' - Jan 24, 2011
- Cholesterol 'increases breast cancer drug's resistance' - Apr 21, 2009
- Possible clues to tamoxifen resistance in breast cancer patients found - Mar 31, 2011
- Preventive use of breast cancer drugs urged - Mar 28, 2011
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
Tags: breast cancer, breast cancer patients, breast cancer risk, breast cancer survivors, breast cancers, cancer research centre, christopher li, dr christopher, drug tamoxifen, earlier research, estrogen receptor, fred hutchinson cancer, fred hutchinson cancer research, hormone therapy, journal cancer, prognosis, severity, strong association, tamoxifen, tumors